מיפג'ין

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

MIFEPRISTONE

Tilgjengelig fra:

A. LAPIDOT PHARMACEUTICALS, LTD

ATC-kode:

G03XB01

Legemiddelform:

טבליה

Sammensetning:

MIFEPRISTONE 200 MG

Administreringsrute:

פומי

Resept typen:

מרשם נדרש

Produsert av:

EXELGYNE LABORATORIES, FRANCE

Terapeutisk gruppe:

MIFEPRISTONE

Terapeutisk område:

MIFEPRISTONE

Indikasjoner:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Autorisasjon dato:

2014-07-31